|
|
||||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
1 Molecular Medicine Unit, St Jamess University Hospital, Leeds LS9 7TF, West Yorkshire, UK
2 Genomics Unit, Glaxo Smith Kline Research and Development, Stevenage SG1 2NY, Hertfordshire, UK
Correspondence to:
Dr J E Crabtree, Level 7, Clinical Sciences Building, St Jamess University Hospital, Leeds LS9 7TF, UK;
msjjc{at}stjames.leeds.ac.uk
Background: Screening of cDNA arrays of the IMAGE library identified human zFOC1 as a differentially expressed cDNA that was upregulated in KATO III gastric cancer cells following stimulation with the gastric pathogen Helicobacter pylori.
Aims: To determine the expression of zFOC1 in gastric mucosa with and without H pylori infection and in patients with gastric cancer.
Results: zFOC1 is localised on chromosome 12q24.3 and encodes a zinc finger protein. Expression studies in human H pylori infected and uninfected gastric biopsies, gastric tumours, and gastric cancer cell lines revealed that zFOCI gene transcripts are significantly higher in gastric cancer than in non-cancerous gastric tissues.
Conclusions: The zFOC1 gene appears to be a tumour marker associated with gastric cancer.
Keywords: gastric cancer; zFOC1; zinc finger protein; cDNA array; Helicobacter pylori
Abbreviations: EST, expressed sequence tag; GAPDH, glyceraldehyde 3 phosphate dehydrogenase; PAI, pathogenicity island; RT-PCR, reverse transcription polymerase chain reaction; SDS, sodium dodecyl sulfate; SCC, saline sodium citrate; UTR, untranslated region
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Molecular Pathology | Journal of Clinical Pathology |